Red Yeast Rice Extract 3% Monacolin K Powder for Nutritional Supplement Formulations

Overview

Red Yeast Rice Extract is a botanical ingredient produced through the fermentation of rice using selected strains of Monascus microorganisms. It contains naturally occurring monacolins, including Monacolin K, which is one of the characteristic bioactive compounds associated with red yeast rice.

Monacolin K is chemically identical to lovastatin, making its content an important parameter in the standardization and quality evaluation of red yeast rice extracts. A 3% Monacolin K specification provides a defined active compound concentration for analytical quality control and ingredient identification.

Red Yeast Rice Extract 3% is commonly supplied as a fine powder for use in capsule and tablet manufacturing. Its application requires careful consideration of active compound content, citrinin contamination, and applicable regulatory requirements.

For manufacturers developing botanical dietary supplement ingredients, product specifications generally include HPLC analysis, citrinin testing, heavy metal analysis, and microbiological evaluation. These parameters help establish ingredient identity, purity, and batch consistency.

Technical Specifications

Functional and Formulation Characteristics

Red Yeast Rice Extract is a botanical ingredient characterized by its naturally occurring Monacolin K content. Monacolin K is structurally identical to lovastatin and is associated with the inhibition of HMG-CoA reductase, an enzyme involved in cholesterol biosynthesis.

This mechanism makes Monacolin K an important compound in research related to cholesterol metabolism and lipid regulation. Red Yeast Rice Extract has therefore been studied in the context of cardiovascular health and lipid metabolism.

In nutritional ingredient development, Red Yeast Rice Extract is commonly associated with the following functional areas:

• Cholesterol Metabolism: Monacolin K inhibits HMG-CoA reductase, which plays a central role in endogenous cholesterol synthesis.

• Lipid Metabolism: Research has investigated its relationship with total cholesterol and LDL cholesterol levels.

• Cardiovascular Health: Red Yeast Rice has been studied in relation to lipid-related cardiovascular risk factors.

• Botanical Nutritional Formulations: Its naturally occurring monacolin compounds make it a characteristic ingredient in red yeast rice-based formulations.

• Combination Formulations: It may be investigated alongside other botanical and nutritional ingredients, subject to safety and regulatory requirements.

Red Yeast Rice Extract is commonly processed into powdered ingredients suitable for capsule and tablet formulations. Its application in finished products requires careful consideration of Monacolin K exposure, potential adverse effects, drug interactions, and applicable regulations.

Application Context

Red Yeast Rice Extract is primarily associated with botanical dietary supplement formulations. Common finished product formats include hard-shell capsules, tablets, and multi-ingredient nutritional supplements.

In capsule manufacturing, the powdered extract can be blended with suitable excipients to achieve uniform filling and consistent ingredient distribution. Tablet formulations may incorporate the extract alongside binders, disintegrants, and other formulation aids.

Red yeast rice ingredients are also encountered in multi-component botanical formulations. However, combinations with other ingredients should be evaluated in accordance with safety assessments and regional regulatory requirements.

An important consideration is that Monacolin K is chemically identical to lovastatin, a prescription medication in certain markets. Consequently, red yeast rice products containing Monacolin K are subject to specific regulatory restrictions and safety considerations.

For example, in the European Union, products providing daily intakes of 3 mg or more of monacolins from red yeast rice have been prohibited under the applicable food supplement framework. In the United States, regulatory classification also requires careful review of the product's composition, intended use, and marketing claims.

Therefore, commercial applications should not automatically be positioned as general food or unrestricted dietary supplement uses. Product developers must confirm the regulatory status of the ingredient and finished formulation in each intended market.

Composition and Standardization

Red Yeast Rice Extract is produced through controlled fermentation of rice using selected Monascus strains. Following fermentation, the material undergoes extraction, concentration, purification, and drying to produce a standardized powder.

Monacolin K is the principal analytical marker specified in this product. A 3% content specification is generally determined through HPLC analysis, providing a quantitative method for monitoring active compound concentration and batch consistency.